NCT02258880View on ClinicalTrials.gov

Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Stroke
Interventions
DRUG

SUN13837

DRUG

placebo

Trial Locations (53)

1449

Alberton

1739

Krugersdorp

6850

Worcester

7130

Somerset West

7350

Bellville

9301

Bloemfontein

11220

Brooklyn

17033

Hershey

19010

Bryn Mawr

19102

Philadelphia

19301

Paoli

23114

Midlothian

23116

Mechanicsville

23226

Richmond

23298

Richmond

27599

Chapel Hill

29203

Columbia

30322

Atlanta

31405

Savannah

33606

Tampa

34239

Sarasota

36693

Mobile

37404

Chattanooga

40536

Lexington

43210

Columbus

48201

Detroit

48236

Detroit

48374

Novi

48705

Southfield

59901

Kalispell

70072

Marrero

70112

New Orleans

70121

New Orleans

77030

Houston

89502

Reno

92024

Encinita

92056

Oceanside

97201

Portland

97213

Portland

97225

Portland

2210001

Naharyia

3109601

Haifa

3339419

Haifa

4428164

Kfar Saba

5262100

Ramat Gan

5822012

Holon

6423906

Tel Aviv

01655

Worcester

08818

Edison

07901

Summit

T6G 2B7

Edmonton

V8R 1J8

Victoria

J7Z 5T3

Saint-Jérôme

Sponsors

Lead Sponsor

Daiichi Sankyo

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Daiichi Sankyo

INDUSTRY